COMPOUNDS FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE

摘要

The invention relates to a method of modulating concentration of Alzheimer's Disease (AD) relevant proteins amyloid precursor protein (APP), beta (beta) and gamma (gamma) secretases and amyloid beta peptide (Abeta), and also relates to a method of reducing Abeta shedding. Furthermore, this invention extends to a compound for use in the treatment of AD, and also to a method of treating AD.